Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 276

Similar articles for PubMed (Select 20009081)

1.

Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy.

Patel C, Yan GX, Kocovic D, Kowey PR.

Circ Arrhythm Electrophysiol. 2009 Dec;2(6):705-11; discussion 712. doi: 10.1161/CIRCEP.109.893628. No abstract available.

2.

Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.

Kuck KH.

Circ Arrhythm Electrophysiol. 2009 Dec;2(6):713-20; discussion 720. doi: 10.1161/CIRCEP.109.896571. No abstract available.

4.

Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs.

Singh S, Murawski MM.

J Cardiovasc Pharmacol Ther. 2007 Sep;12(3):175-80. Review.

PMID:
17875944
5.

[Frequent ventricular tachycardias: antiarrhythmic drug treatment or catheter ablation?].

Tanner H, Hindricks G, Kottkamp H.

Herz. 2005 Nov;30(7):613-8. Review. German.

PMID:
16333587
6.

Clinical assessment and management of patients with implanted cardioverter-defibrillators presenting to nonelectrophysiologists.

Stevenson WG, Chaitman BR, Ellenbogen KA, Epstein AE, Gross WL, Hayes DL, Strickberger SA, Sweeney MO; Subcommittee on Electrocardiography and Arrhythmias of the American Heart Association Council on Clinical Cardiology; Heart Rhythm Society.

Circulation. 2004 Dec 21;110(25):3866-9. Review.

8.

Antiarrhythmic therapy for the prevention of sudden cardiac death.

Cairns J, Kerr C, Teo K.

Can J Cardiol. 2000 Jun;16 Suppl C:29C-33C. Review. No abstract available.

PMID:
10887276
9.
10.

Non-pharmacological management of ventricular tachycardia.

Chinushi M, Aizawa Y.

Circ J. 2007;71 Suppl A:A97-105. Review.

11.

Combining shock reduction strategies to enhance ICD therapy: a role for computer modeling.

Volosin KJ, Exner DV, Wathen MS, Sherfesee L, Scinicariello AP, Gillberg JM.

J Cardiovasc Electrophysiol. 2011 Mar;22(3):280-9. doi: 10.1111/j.1540-8167.2010.01918.x. Epub 2010 Oct 11.

PMID:
20958831
12.

Appropriate therapy but not inappropriate shocks predict survival in implantable cardioverter defibrillator patients.

Dichtl W, Wolber T, Paoli U, Brüllmann S, Stühlinger M, Berger T, Spuller K, Strasak A, Pachinger O, Haegeli LM, Duru F, Hintringer F.

Clin Cardiol. 2011 Jul;34(7):433-6. doi: 10.1002/clc.20910. Epub 2011 Jun 15.

PMID:
21678454
13.

Interactions of antiarrhythmic drugs and implantable devices in controlling ventricular tachycardia and fibrillation.

Rajawat YS, Dias D, Gerstenfeld EP, Dixit S, Shah B, Russo AM, Marchlinski FE.

Curr Cardiol Rep. 2002 Sep;4(5):434-40. Review.

PMID:
12169241
14.

Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?

Wichter T, Paul TM, Eckardt L, Gerdes P, Kirchhof P, Böcker D, Breithardt G.

Herz. 2005 Mar;30(2):91-101. Review.

PMID:
15875097
15.

The efficacy of implantable cardioverter-defibrillators in heart transplant recipients: results from a multicenter registry.

Tsai VW, Cooper J, Garan H, Natale A, Ptaszek LM, Ellinor PT, Hickey K, Downey R, Zei P, Hsia H, Wang P, Hunt S, Haddad F, Al-Ahmad A.

Circ Heart Fail. 2009 May;2(3):197-201. doi: 10.1161/CIRCHEARTFAILURE.108.814525. Epub 2009 Apr 30.

16.

Approach to reduction of ventricular arrhythmias and implantable cardioverter-defibrillator therapies in patients with heart failure.

Sengupta J, Abdelhadi R.

Curr Opin Cardiol. 2013 May;28(3):337-43. doi: 10.1097/HCO.0b013e3283604420. Review.

PMID:
23549236
17.

Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.

Klein RC, Raitt MH, Wilkoff BL, Beckman KJ, Coromilas J, Wyse DG, Friedman PL, Martins JB, Epstein AE, Hallstrom AP, Ledingham RB, Belco KM, Greene HL; AVID Investigators.

J Cardiovasc Electrophysiol. 2003 Sep;14(9):940-8.

PMID:
12950538
18.

Evidence rather than costs must guide use of the implantable cardioverter defibrillator.

Delacretaz E, Schlaepfer J, Metzger J, Fromer M, Kappenberger L.

Am J Cardiol. 2000 Nov 2;86(9A):52K-57K. Review.

PMID:
11084101
19.

Management of ventricular tachycardia in heart failure.

Baher A, Valderrabano M.

Methodist Debakey Cardiovasc J. 2013 Jan-Mar;9(1):20-5. Review.

20.

Combining antiarrhythmic drugs and implantable devices therapy: benefits and outcome.

Santini M, Pandozi C, Ricci R.

J Interv Card Electrophysiol. 2000 Jan;4 Suppl 1:65-8. Review.

PMID:
10590491
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk